GB201704386D0 - Method for identification of sofosbuvir resistant patients - Google Patents

Method for identification of sofosbuvir resistant patients

Info

Publication number
GB201704386D0
GB201704386D0 GBGB1704386.0A GB201704386A GB201704386D0 GB 201704386 D0 GB201704386 D0 GB 201704386D0 GB 201704386 A GB201704386 A GB 201704386A GB 201704386 D0 GB201704386 D0 GB 201704386D0
Authority
GB
United Kingdom
Prior art keywords
sofosbuvir
identification
resistant patients
patients
resistant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1704386.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Queen Mary University of London
Original Assignee
Queen Mary University of London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Queen Mary University of London filed Critical Queen Mary University of London
Priority to GBGB1704386.0A priority Critical patent/GB201704386D0/en
Publication of GB201704386D0 publication Critical patent/GB201704386D0/en
Priority to PCT/GB2018/050718 priority patent/WO2018172759A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/18—Togaviridae; Flaviviridae
    • G01N2333/183—Flaviviridae, e.g. pestivirus, mucosal disease virus, bovine viral diarrhoea virus, classical swine fever virus (hog cholera virus) or border disease virus
    • G01N2333/186—Hepatitis C; Hepatitis NANB
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GBGB1704386.0A 2017-03-20 2017-03-20 Method for identification of sofosbuvir resistant patients Ceased GB201704386D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1704386.0A GB201704386D0 (en) 2017-03-20 2017-03-20 Method for identification of sofosbuvir resistant patients
PCT/GB2018/050718 WO2018172759A1 (en) 2017-03-20 2018-03-20 Method for identification of sofosbuvir resistant patients

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1704386.0A GB201704386D0 (en) 2017-03-20 2017-03-20 Method for identification of sofosbuvir resistant patients

Publications (1)

Publication Number Publication Date
GB201704386D0 true GB201704386D0 (en) 2017-05-03

Family

ID=58688476

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1704386.0A Ceased GB201704386D0 (en) 2017-03-20 2017-03-20 Method for identification of sofosbuvir resistant patients

Country Status (2)

Country Link
GB (1) GB201704386D0 (en)
WO (1) WO2018172759A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024123010A1 (en) * 2022-12-05 2024-06-13 국립암센터 Luminescent platform for dual measurement of hcv/mir-122 activity, and use of derived substance rigosertib for treatment of sofosbuvir-resistant hcv

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100284966A1 (en) * 2005-11-04 2010-11-11 Striker Robert T Methods and Compositions for Managing Resistance of Hepatitis C Virus to Immunosuppressant
US20080182895A1 (en) * 2006-08-25 2008-07-31 Howe Anita Y M Identification and characterization of hcv replicon variants with reduced susceptibility to hcv-796, and methods related thereto
CN104126008B (en) 2011-08-31 2017-03-22 日本国立感染症研究所 Nucleic acid construct including nucleic acid derived from genotype 3[alpha] HCV genome
GB201119011D0 (en) 2011-11-03 2011-12-14 Queen Mary Innovation Ltd Method
US20140274935A1 (en) * 2013-03-15 2014-09-18 Laboratory Corporation Of America Holdings Methods for determining viral sensitivity to viral inhibitors

Also Published As

Publication number Publication date
WO2018172759A1 (en) 2018-09-27

Similar Documents

Publication Publication Date Title
HK1251614A1 (en) Method for the treatment of malignancies
SG10202011241TA (en) Method of identifying musk compounds
HK1252568A1 (en) A method of treatment
GB2569852B (en) Method for recovering patient registration
IL243499A0 (en) Identification method of an entity
EP3684342C0 (en) Method of treatment
HK1258994A1 (en) Methods for treatment of diseases
HK1247818A1 (en) Method of treating diseases
GB201706406D0 (en) Method of treatment
GB201802795D0 (en) Patient assessment method
GB201815588D0 (en) Method of treatment
IL260194B (en) Method for the in-ovo sex identification of chicks
GB2554178B (en) Method for identification of a vessel
GB201717945D0 (en) Method for treatment of cancer
PT3458646T (en) Method and treatment system for making of paper
PL3380983T3 (en) Method for the identification of security processors
GB201602802D0 (en) Method of treatment
HK1250243A1 (en) A method of treatment
GB201704386D0 (en) Method for identification of sofosbuvir resistant patients
ZA202005630B (en) A system for identifying persons of interest
IL261475A (en) Method of identifying optimal zones for electropulse therapy (variants)
GB201703705D0 (en) Method of conrol
GB201509658D0 (en) Method of diagnosis
GB201720439D0 (en) Method of treatment
GB201718589D0 (en) Method of treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)